review · Inflammopharmacology

Efficacy and safety of Mirikizumab in the treatment of moderate to severe inflammatory bowel diseases: a systematic review and updated meta-analysis

Joël Gabin Konlack Mekontso
Guy Loic Nguefang Tchoukeu
Jarin Prasa
Samuel G. J. Fodop
Joseph Yvan Bena Nnang
Ticha B T Tembi
Anifatou B. Kortim
Bishoy I. B. Elkoumes
Akil Olliverre
John Trillo

20251 citationUniversity of Bamenda

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Inflammatory Bowel Disease
Psoriasis: Treatment and Pathogenesis
Rheumatoid Arthritis Research and Therapies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s10787-025-01971-z

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.